Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

Finasteride effectively treats frontal hair loss with few side effects.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Dutasteride works better than finasteride for hair growth with similar side effects.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Finasteride use changes brain chemicals, causing lasting sexual issues and anxiety/depression.

Dutasteride mesotherapy helps treat male hair loss but may harm sperm and sexual function.

The document suggests that finasteride may cause depression and suicidal thoughts, while prostate surgery does not harm sexual health.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Men using steroids or finasteride to look more attractive may harm their fertility and sexual function, creating a paradox where they seem fit but may be less able to reproduce.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Puberty involves complex hormonal changes, varies by gender and ethnicity, and requires careful monitoring for abnormalities.

Young men with mild hair loss who experience significant social and emotional distress are more likely to have sexual problems.

The article concludes that understanding the causes of hair loss and using continuous treatments like minoxidil and finasteride can help manage it, despite potential side effects.

Patients should consult urologists for evidence-based erectile dysfunction treatments.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

Dutasteride is safe and effective long-term for male hair loss.

Sexual activity can spread T. interdigitale, needing quick antifungal treatment to avoid permanent scarring.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Knowing about finasteride's sexual side effects increases reported dysfunction.